HR 4479 United States House · 117th Congress

Facilitating Innovative Nuclear Diagnostics Act of 2021

Summary

Facilitating Innovative Nuclear Diagnostics Act of 2021 This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2022 and as adjusted based on a specified fee schedule factor in each year thereafter.

Bill status in committee 1 of 4 stages cleared

Introduction

Jul 2021

Committee Review

Floor Vote

President

Introduced Jul 16, 2021 Last action Jul 19, 2021

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jul 19, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jul 16, 2021

Committee

Referred to the Subcommittee on Health.

lower

Jul 16, 2021

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jul 16, 2021

Introduced

Introduced in House

lower

1 primary · 41 co-sponsors